How An $11.4 Billion Takeover Will Deepen Pfizer's Efforts In CancerInvestors Business Daily • 06/17/19
S&P places Pfizer ratings on CreditWatch negative after $11.4 billion Array dealMarket Watch • 06/17/19
Why Is Array BioPharma (ARRY) Up 27.1% Since Last Earnings Report?Zacks Investment Research • 06/06/19